AdventHealth is First in Florida to Deploy Next-Generation Surgical Robot

CELEBRATION, Fla. – A surgical team at AdventHealth recently became the first in the state to use a groundbreaking new surgical robot.

AdventHealth is first in Florida to deploy next-generation surgical robot

Dr. Vipul Patel, a world leader in robot-assisted prostatectomy procedures, performed the first procedure in early April using the da Vinci 5 system, and will continue to utilize the new surgical robot.

The da Vinci 5 succeeds the da Vinci Xi, which has been in wide use at AdventHealth and health systems around the world since its debut in 2014. It has been used in more than 7 million procedures to date, according to manufacturer Intuitive.

“This new technology is the next step in the future of robotic surgery,” Patel said. “The da Vinci 5 promises new innovation to facilitate improved surgeon comfort and data feedback.”

Among the new features:

  • More ergonomic design for surgeon comfort
  • Next-generation 3D display
  • 10,000 times the computing power of the previous model
  • Connectivity with other technology in the OR that may streamline procedures and save time for surgical teams.

Robotic surgery is minimally invasive, and has a track record indicating improved outcomes and better patient experience in certain procedures compared to traditional open surgeries or minimally invasive laparoscopic procedures.

“At AdventHealth, we pride ourselves on being leaders in health care innovation,” said Amanda Maggard, CEO of AdventHealth Celebration. “Bringing this technology right here to Celebration allows us to provide leading-edge treatment that’s convenient and close to home.”

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma

AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...

Read Article about "New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma"
View More Articles